Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 59

Sort by

Sort Order Select

Journal Articles

Updated Results from a Matching-Adjusted Indirect Comparison of Efficacy Outcomes of Isatuximab Plus Carfilzomib and Dexamethasone Versus Daratumumab Plus Lenalidomide and Dexamethasone in Patients with Relapsed and/or Refractory Multiple Myeloma

Joshua Richter, Peggy L Lin, Viviana Garcia-Horton, Patricia Guyot, Zheng-Yi Zhou, Mark Sievert

Blood (2023) 142 (Supplement 1): 6734.

https://doi.org/10.1182/blood-2023-188582

Published: 2023

Journal Articles

In Vivo Reprogramming of Adult Liver Sinusoidal Vascular Endothelial Cells into a Hematopoietic Stem and Progenitor Cell Niche

Tianxiao Han, Rajesh D. Gunage, Ran Jing, Alexandra F. Corbin, Kenny Zhi Ming Chen, Yang Tang, Olivia Stockard, Song Yang, Yi Zhou, George Q. Daley, Thorsten M. Schlaeger, Leonard I. Zon

Blood (2023) 142 (Supplement 1): 4071.

https://doi.org/10.1182/blood-2023-180300

Published: 2023

Journal Articles

Does Detection of <20% Lymphoblasts in Patients with CML Herald Imminent Blast Crisis? a Study from BCR::ABL1 Pathology Group

Blood (2023) 142 (Supplement 1): 6364.

https://doi.org/10.1182/blood-2023-187020

Published: 2023

Journal Articles

Selinexor, Venetoclax, and Dexamethasone in t(11;14)-Positive Relapsed/Refractory Multiple Myeloma (SELVEDge Study)

Blood (2023) 142 (Supplement 1): 6740.

https://doi.org/10.1182/blood-2023-180939

Published: 2023

Journal Articles

Prevalence of Ocular Comorbidities in Elderly Patients with Multiple Myeloma in the US: An Analysis of 100% Medicare Sample Data during 2007-2020

Sikander Ailawadhi, Qiufei Ma, Jessica J. Jalbert, Mo Zhou, Zheng-Yi Zhou, Nathaniel Downes, Adina Zhang, Lei Chi, Christian Hampp, Xue Song, Irene Noguera-Troise, Jonathan Weyne, Glenn S. Kroog, Karen Rodriguez Lorenc

Blood (2022) 140 (Supplement 1): 5272–5273.

https://doi.org/10.1182/blood-2022-158401

Published: 2022

Journal Articles

Treatment Patterns and Economic Burden Among Elderly Patients with Acute Myeloid Leukemia Treated with Hypomethylating Agents: A SEER-Medicare Analysis

Andrew M. Brunner, David Huggar, Ronda Copher, Zheng-Yi Zhou, Miriam L. Zichlin, Annika Anderson, Nathaniel Downes, Ali McBride

Blood (2021) 138 (Supplement 1): 4975.

https://doi.org/10.1182/blood-2021-145593

Published: 2021

Journal Articles

Acute myeloid leukemia measurable residual disease detection by flow cytometry in peripheral blood vs bone marrow

Colin D. Godwin, Yi Zhou, Megan Othus, Mallette M. Asmuth, Carole M. Shaw, Kelda M. Gardner, Brent L. Wood, Roland B. Walter, Elihu H. Estey

Blood (2021) 137 (4): 569–572.

https://doi.org/10.1182/blood.2020006219

Published: 2021

Journal Articles

Association between Spending in Oncology Care Model-Defined Episodes and Overall Survival in Multiple Myeloma Using 2012-2017 Medicare Data

Ruben Niesvizky, MD, Zoe Clancy, Ronda Copher, PhD, Ryan B. Thomas, MD, Cynthia Z. Qi, MBA, Zheng-Yi Zhou, Miriam L. Zichlin, Sarah H. Koenigsberg, James E. Signorovitch

Blood (2020) 136 (Supplement 1): 22–23.

https://doi.org/10.1182/blood-2020-136284

Published: 2020

Journal Articles

Economic Burden of Newly Diagnosed Acute Myeloid Leukemia: A Retrospective Study Using the SEER-Medicare Database

Ashley Tabah, David Huggar, Krystal Huey, Ronda Copher, PhD, Zheng-Yi Zhou, Miriam L. Zichlin, Sarah H. Koenigsberg, Andrew M. Brunner

Blood (2020) 136 (Supplement 1): 45.

https://doi.org/10.1182/blood-2020-136768

Published: 2020

Journal Articles

Transcription Factor Induction of Ectopic Vascular Blood Stem Cell Niches In Vivo

Blood (2019) 134 (Supplement_1): 525.

https://doi.org/10.1182/blood-2019-127219

Published: 2019

Journal Articles

Comparison of Acute Myeloid Leukemia Measurable Residual Disease Detection By Flow Cytometry in Peripheral Blood and Bone Marrow

Colin D. Godwin, MDMPhil, Yi Zhou, MD PhD, Megan Othus, PhD, Carole M. Shaw, BA, Kelda M. Gardner, PA-C, Brent L Wood, MD PhD, Roland B. Walter, MD PhD MS, Elihu H. Estey, MD

Blood (2019) 134 (Supplement_1): 2729.

https://doi.org/10.1182/blood-2019-127128

Published: 2019

Journal Articles

Model of Short and Long-Term Outcomes of Emicizumab Prophylaxis Treatment for Persons with Hemophilia Α

Arash Mahajerin, MD MS, Zheng-Yi Zhou, PhD, Karina Raimundo, Anisha Patel, Simeng Han, Yusi Ji, Jia Zhong, Keith Betts

Blood (2018) 132 (Supplement 1): 3511.

https://doi.org/10.1182/blood-2018-99-112418

Published: 2018

Journal Articles

Cost-Effectiveness Analysis of Lenalidomide for Maintenance Therapy after Autologous Stem Cell Transplant (ASCT) in Newly Diagnosed Multiple Myeloma (NDMM) Patients: A United States Payer Perspective

Zheng-Yi Zhou, PhD, Kejal Parikh, Xinglei Chai, Ariel Rokito, Chuka Udeze, Jipan Xie, Amit Agarwal

Blood (2018) 132 (Supplement 1): 3535.

https://doi.org/10.1182/blood-2018-99-112942

Published: 2018

Journal Articles

Treatment Patterns and Healthcare Resource Utilization in Patients with Relapsed/Refractory Acute Myeloid Leukemia and a Subset with IDH1-Mutation: A United States Medical Chart Review Study

James D. Griffin, MD, Mike Storm, MSc, Ken Wilhelm, MD, Audra Boscoe, PhD, Dendy Macaulay, PhD, Zheng-Yi Zhou, PhD, Elizabeth Faust, MBA/MPH, Claudia Cheung, MS

Blood (2018) 132 (Supplement 1): 5864.

https://doi.org/10.1182/blood-2018-99-116495

Published: 2018

Journal Articles

Transcriptional Signaling Centers Govern Human Erythropoiesis and Harbor Genetic Variations of Red Blood Cell Traits

Blood (2018) 132 (Supplement 1): 1277.

https://doi.org/10.1182/blood-2018-99-118637

Published: 2018

Journal Articles

Racial Disparities in Treatment Patterns and Outcomes Among Patients with Multiple Myeloma: A SEER-Medicare Analysis

Sikander Ailawadhi, Kejal Parikh, BSPharm, MS, Zhou Zhou, MS, Wenxi Tang, MS, Zoe Clancy, MS, PharmD, Claudia Cheung, MS, Zheng-Yi Zhou, PhD, Jipan Xie, MD PhD, Safiya Abouzaid, MPH, PharmD

Blood (2017) 130 (Supplement 1): 3426.

https://doi.org/10.1182/blood.V130.Suppl_1.3426.3426

Published: 2017

Journal Articles

Distinct Signaling Centers Define Stages of Human Erythropoiesis and Harbor Common Variations of Red Blood Cell Traits

Avik Choudhuri, PhD, Eirini Trompouki, PhD, Brian J Abraham, PhD, William Mallard, Min-Lee Yang, PhD, Alireza Ghamari, PhD, Kanen Hoi, Barbara Hummel, Sonja Boatman, Victoria Chan, Teresa V. Bowman, PhD, Song Yang, Yi Zhou, Sinichiro Takahashi, MD PhD, Alan B. Cantor, MD, PhD, Santhi Ganesh, MD, John Rinn, PhD, Richard A. Young, PhD, Leonard I. Zon, MD

Blood (2017) 130 (Supplement 1): 773.

https://doi.org/10.1182/blood.V130.Suppl_1.773.773

Published: 2017

Journal Articles

Significance of Peri-Transplant Measurable Residual Disease Detected By Multiparameter Flow Cytometry and Next-Generation Sequencing in Adults with NPM1 -Mutated Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation

Yi Zhou, MD, Megan Othus, PhD, Elihu H. Estey, MD, Roland B. Walter, MD PhD, David Wu, MD PhD, Brent Wood, MDPhD

Blood (2017) 130 (Supplement 1): 2701.

https://doi.org/10.1182/blood.V130.Suppl_1.2701.2701

Published: 2017

Journal Articles

Relapse of an acute leukemia of mixed lineage as an isolated orbital mass

Xiao Yi Zhou, Amir Behdad

Blood (2017) 130 (7): 953.

https://doi.org/10.1182/blood-2017-04-781906

Published: 2017

Journal Articles

Eicosanoid-GPCR Signaling Enhances Hematopoiesis and Marrow Transplant

Jamie L Lahvic, BA, Michelle B Ammerman, BA, Pulin Li, PhD, Song Yang, PhD, Nan Chiang, PhD, Michael Chase, BA, Olivia Weis, Yi Zhou, PhD, Charles Serhan, PhD, Leonard I. Zon, MD

Blood (2016) 128 (22): 495.

https://doi.org/10.1182/blood.V128.22.495.495

Published: 2016

NARROW

Updated Results from a Matching-Adjusted Indirect Comparison of Efficacy Outcomes of Isatuximab Plus Carfilzomib and Dexamethasone Versus Daratumumab Plus Lenalidomide and Dexamethasone in Patients with Relapsed and/or Refractory Multiple Myeloma

In Vivo Reprogramming of Adult Liver Sinusoidal Vascular Endothelial Cells into a Hematopoietic Stem and Progenitor Cell Niche

Does Detection of <20% Lymphoblasts in Patients with CML Herald Imminent Blast Crisis? a Study from BCR::ABL1 Pathology Group

Selinexor, Venetoclax, and Dexamethasone in t(11;14)-Positive Relapsed/Refractory Multiple Myeloma (SELVEDge Study)

Prevalence of Ocular Comorbidities in Elderly Patients with Multiple Myeloma in the US: An Analysis of 100% Medicare Sample Data during 2007-2020

Treatment Patterns and Economic Burden Among Elderly Patients with Acute Myeloid Leukemia Treated with Hypomethylating Agents: A SEER-Medicare Analysis

Acute myeloid leukemia measurable residual disease detection by flow cytometry in peripheral blood vs bone marrow

Association between Spending in Oncology Care Model-Defined Episodes and Overall Survival in Multiple Myeloma Using 2012-2017 Medicare Data

Economic Burden of Newly Diagnosed Acute Myeloid Leukemia: A Retrospective Study Using the SEER-Medicare Database

Transcription Factor Induction of Ectopic Vascular Blood Stem Cell Niches In Vivo

Comparison of Acute Myeloid Leukemia Measurable Residual Disease Detection By Flow Cytometry in Peripheral Blood and Bone Marrow

Model of Short and Long-Term Outcomes of Emicizumab Prophylaxis Treatment for Persons with Hemophilia Α

Cost-Effectiveness Analysis of Lenalidomide for Maintenance Therapy after Autologous Stem Cell Transplant (ASCT) in Newly Diagnosed Multiple Myeloma (NDMM) Patients: A United States Payer Perspective

Treatment Patterns and Healthcare Resource Utilization in Patients with Relapsed/Refractory Acute Myeloid Leukemia and a Subset with IDH1-Mutation: A United States Medical Chart Review Study

Transcriptional Signaling Centers Govern Human Erythropoiesis and Harbor Genetic Variations of Red Blood Cell Traits

Racial Disparities in Treatment Patterns and Outcomes Among Patients with Multiple Myeloma: A SEER-Medicare Analysis

Distinct Signaling Centers Define Stages of Human Erythropoiesis and Harbor Common Variations of Red Blood Cell Traits

Significance of Peri-Transplant Measurable Residual Disease Detected By Multiparameter Flow Cytometry and Next-Generation Sequencing in Adults with NPM1 -Mutated Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation

Relapse of an acute leukemia of mixed lineage as an isolated orbital mass

Eicosanoid-GPCR Signaling Enhances Hematopoiesis and Marrow Transplant

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only